Back
IBBIS at the AI Action Summit
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
This post documents IBBIS's participation in a high-level international policy event, relevant to those tracking AI governance efforts around biological risks and dual-use technology safeguards.
Metadata
Importance: 38/100blog postnews
Summary
IBBIS participated in a side event at the February 2025 AI Action Summit, contributing expert perspectives on DNA sequence screening and the governance challenges at the intersection of AI and the life sciences. The organization highlighted the lack of globally harmonized standards for DNA synthesis screening, dual-use technology risks, and geopolitical complexities in biosecurity governance. The engagement connects to IBBIS's broader work on international biosecurity standards under ISO 20688-2.
Key Points
- •IBBIS highlighted the absence of globally harmonized standards for DNA synthesis screening at the AI Action Summit side event in February 2025.
- •Discussions focused on governance frameworks needed to prevent high-consequence biological harms at the AI-biology (AIxBio) nexus.
- •Panelists included representatives from the EU AI Office and the Frontier Model Forum, reflecting cross-sector coordination on AI biosecurity.
- •IBBIS emphasized dual-use technology risks and the evolving geopolitical context as key challenges for biosecurity governance.
- •The event was co-hosted by Johns Hopkins Bloomberg School of Public Health and aimed to shape future international norms for AI in life sciences.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Mar 20, 20265 KB
- [About](https://ibbis.bio/about/)
- [People](https://ibbis.bio/about/people/)
- [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
- [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
- [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
- [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
- [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
- [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
- [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)
[](https://ibbis.bio/)
- [About](https://ibbis.bio/about/)
- [People](https://ibbis.bio/about/people/)
- [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
- [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
- [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
- [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
- [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
- [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
- [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)
IBBIS at the AI Action Summit: Advancing Biosecurity in the Age of AI
The International Biosecurity and Biosafety Initiative for Science (IBBIS) participated in the [AI Action Summit](https://www.elysee.fr/en/sommet-pour-l-action-sur-l-ia) in February 2025, contributing to the critical discussion on the intersection of artificial intelligence (AI) and the life sciences. The lead of our international standards project, Sophie Peresson, participated in a side event, [_Realizing the Transformative Power of AI in the Life Sciences: Priorities for Safety & Security_](https://web.cvent.com/event/379770e1-7a41-4058-9cab-600e25682c76/summary), co-hosted by the Johns Hopkins Bloomberg School of Public Health and Pour Demain.
The event featured a discussion on “Governance and AI Model Safety Measures Needed to Prevent High-Consequence Biological Harms”. The panel, moderated by Tom Inglesby, Director of the Johns Hopkins Center for Health Security, brought together leading experts to explore how to assess and address pandemic-level risks at the AI-biology nexus (AIxBio). Discussions centered on the need for expert- and industry-informed guiding principles that could shape future international norms and frameworks. These frameworks aim to maximize the benefits of AI in health and biotechnology while mitigating potential security threats.
IBBIS provided insights on DNA sequence s
... (truncated, 5 KB total)Resource ID:
62493ecf44df1672 | Stable ID: MTU2OTZmND